Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Dexcom (DXCM) Other Non Operating Income (2016 - 2025)

Historic Other Non Operating Income for Dexcom (DXCM) over the last 13 years, with Q4 2025 value amounting to $17.7 million.

  • Dexcom's Other Non Operating Income fell 2098.21% to $17.7 million in Q4 2025 from the same period last year, while for Dec 2025 it was $176.6 million, marking a year-over-year increase of 6201.83%. This contributed to the annual value of $176.6 million for FY2025, which is 6201.83% up from last year.
  • According to the latest figures from Q4 2025, Dexcom's Other Non Operating Income is $17.7 million, which was down 2098.21% from $109.8 million recorded in Q3 2025.
  • In the past 5 years, Dexcom's Other Non Operating Income registered a high of $109.8 million during Q3 2025, and its lowest value of -$8.3 million during Q4 2021.
  • Moreover, its 5-year median value for Other Non Operating Income was $19.2 million (2025), whereas its average is $19.9 million.
  • As far as peak fluctuations go, Dexcom's Other Non Operating Income crashed by 90000.0% in 2022, and later skyrocketed by 278461.54% in 2023.
  • Over the past 5 years, Dexcom's Other Non Operating Income (Quarter) stood at -$8.3 million in 2021, then soared by 196.39% to $8.0 million in 2022, then soared by 266.25% to $29.3 million in 2023, then dropped by 23.55% to $22.4 million in 2024, then decreased by 20.98% to $17.7 million in 2025.
  • Its Other Non Operating Income was $17.7 million in Q4 2025, compared to $109.8 million in Q3 2025 and $28.5 million in Q2 2025.